Strs Ohio Sells 2,405 Shares of Cigna Group $CI

Strs Ohio lessened its holdings in shares of Cigna Group (NYSE:CI) by 3.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 59,700 shares of the health services provider’s stock after selling 2,405 shares during the period. Strs Ohio’s holdings in Cigna Group were worth $16,431,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Beacon Financial Strategies CORP bought a new position in shares of Cigna Group during the fourth quarter valued at approximately $28,000. Lodestone Wealth Management LLC bought a new position in shares of Cigna Group during the fourth quarter valued at approximately $32,000. Collier Financial bought a new position in shares of Cigna Group during the third quarter valued at approximately $34,000. Activest Wealth Management raised its holdings in shares of Cigna Group by 1,050.0% during the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after acquiring an additional 126 shares in the last quarter. Finally, True Wealth Design LLC grew its stake in Cigna Group by 116.4% in the fourth quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock worth $43,000 after purchasing an additional 85 shares during the period. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Everett Neville sold 1,719 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.60% of the company’s stock.

Key Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
• Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an “outperform” rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
• Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
• Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
• Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
• Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

Cigna Group Trading Up 0.1%

Cigna Group stock opened at $283.14 on Monday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The stock has a market capitalization of $74.62 billion, a PE ratio of 12.00, a price-to-earnings-growth ratio of 0.98 and a beta of 0.30. The business’s fifty day moving average is $274.34 and its 200 day moving average is $276.63.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same period last year, the firm posted $6.74 earnings per share. Cigna Group’s revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts predict that Cigna Group will post 30.41 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 28.13%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Zacks Research raised Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Barclays upped their price target on Cigna Group from $303.00 to $310.00 and gave the stock an “overweight” rating in a research note on Friday. Jefferies Financial Group reduced their price target on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research note on Monday, April 20th. Robert W. Baird set a $337.00 price target on Cigna Group in a research note on Friday. Finally, Piper Sandler reduced their price target on Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $336.20.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.